We provide further evidence to support the role of KRAS pathogenic variants in spinal arteriovenous metameric syndrome (SAMS) and HRAS variants in AVMs with tissue overgrowth. This evidence concerns the gene HRAS and short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome.